Prediction of the in vitro permeability determined in Caco-2 cells by using artificial neural networks.

Caco-2 cells are currently the most used in vitro tool for prediction of the potential oral absorption of new drugs. The existence of computational models based on this data may potentiate the early selection process of new drugs, but the current models are based on a limited number of cases or on a reduced molecular space. We present an artificial neural network based only on calculated molecular descriptors for modelling 296 in vitro Caco-2 apparent permeability (P(app)) drug values collected in the literature using also a pruning procedure for reducing the descriptors space. LogP(app) values were divided into a training group of 192 drugs for network optimization and a testing group of another 59 drugs for early stop and internal validation resulting in correlations of 0.843 and 0.702 and RMSE of 0.546 and 0.791 for the training and testing group, respectively. External validation was made with an additional group of 45 drugs with a correlation of 0.774 and RMSE of 0.601. The selected molecular descriptors encode information related to the lipophilicity, electronegativity, size, shape and flexibility characteristics of the molecules, which are related to drug absorption. This model may be a valuable tool for prediction and simulation in the drug development process, as it allows the in silico estimation of the in vitro Caco-2 apparent permeability.

[1]  M. Cavet,et al.  Transepithelial transport of the fluoroquinolone ciprofloxacin by human airway epithelial Calu-3 cells , 1997, Antimicrobial agents and chemotherapy.

[2]  Gilles Klopman,et al.  ADME evaluation. 2. A computer model for the prediction of intestinal absorption in humans. , 2002, European journal of pharmaceutical sciences : official journal of the European Federation for Pharmaceutical Sciences.

[3]  E. Furfine,et al.  Preclinical Pharmacology and Pharmacokinetics of GW433908, a Water-Soluble Prodrug of the Human Immunodeficiency Virus Protease Inhibitor Amprenavir , 2004, Antimicrobial Agents and Chemotherapy.

[4]  Ming Hu,et al.  Mechanism of L-α-Methyldopa Transport Through a Monolayer of Polarized Human Intestinal Epithelial Cells (Caco-2) , 1990, Pharmaceutical Research.

[5]  B B Brodie,et al.  Mechanisms of drug absorption and of drug solution. , 1972, Pharmacology.

[6]  Leo Abrahamse,et al.  Comparison of in Vitro Models for the Prediction of Compound Absorption across the Human Intestinal Mucosa , 2004, Journal of biomolecular screening.

[7]  Kiyohiko Sugano,et al.  Correction of Permeability with Pore Radius of Tight Junctions in Caco-2 Monolayers Improves the Prediction of the Dose Fraction of Hydrophilic Drugs Absorbed by Humans , 2004, Pharmaceutical Research.

[8]  Cheng-Pang Hsu,et al.  Optimizing Caco-2 cell monolayers to increase throughput in drug intestinal absorption analysis. , 2001, Journal of pharmacological and toxicological methods.

[9]  Anders Karlén,et al.  Hydrogen bonding descriptors in the prediction of human in vivo intestinal permeability. , 2003, Journal of molecular graphics & modelling.

[10]  J. Pachot,et al.  Experimental estimation of the role of P-Glycoprotein in the pharmacokinetic behaviour of telithromycin, a novel ketolide, in comparison with roxithromycin and other macrolides using the Caco-2 cell model. , 2003, Journal of pharmacy & pharmaceutical sciences : a publication of the Canadian Society for Pharmaceutical Sciences, Societe canadienne des sciences pharmaceutiques.

[11]  H Lennernäs,et al.  Correlation of human jejunal permeability (in vivo) of drugs with experimentally and theoretically derived parameters. A multivariate data analysis approach. , 1998, Journal of medicinal chemistry.

[12]  Li Di,et al.  Combined application of parallel artificial membrane permeability assay and Caco-2 permeability assays in drug discovery. , 2004, Journal of pharmaceutical sciences.

[13]  S. Stavchansky,et al.  Link between drug absorption solubility and permeability measurements in Caco-2 cells. , 1998, Journal of pharmaceutical sciences.

[14]  J. Dearden,et al.  In Silico Prediction of Physicochemical Properties , 2007 .

[15]  Paulo Paixão,et al.  Prediction of drug distribution within blood. , 2009, European journal of pharmaceutical sciences : official journal of the European Federation for Pharmaceutical Sciences.

[16]  Igor V. Tetko,et al.  Virtual Computational Chemistry Laboratory – Design and Description , 2005, J. Comput. Aided Mol. Des..

[17]  J R Chretien,et al.  Estimation of blood-brain barrier crossing of drugs using molecular size and shape, and H-bonding descriptors. , 1998, Journal of drug targeting.

[18]  P. Selzer,et al.  Fast calculation of molecular polar surface area as a sum of fragment-based contributions and its application to the prediction of drug transport properties. , 2000, Journal of medicinal chemistry.

[19]  G. Knipp,et al.  Delineation of Human Peptide Transporter 1 (hPepT1)-Mediated Uptake and Transport of Substrates with Varying Transporter Affinities Utilizing Stably Transfected hPepT1/Madin-Darby Canine Kidney Clones and Caco-2 Cells , 2005, Journal of Pharmacology and Experimental Therapeutics.

[20]  S. So,et al.  Application of neural networks: quantitative structure-activity relationships of the derivatives of 2,4-diamino-5-(substituted-benzyl)pyrimidines as DHFR inhibitors. , 1992, Journal of medicinal chemistry.

[21]  Anton J Hopfinger,et al.  Combined 4D-fingerprint and clustering based membrane-interaction QSAR analyses for constructing consensus Caco-2 cell permeation virtual screens. , 2008, Journal of pharmaceutical sciences.

[22]  Päivi Tammela,et al.  Permeability characteristics and membrane affinity of flavonoids and alkyl gallates in Caco-2 cells and in phospholipid vesicles. , 2004, Archives of biochemistry and biophysics.

[23]  Hiroshi Saitoh,et al.  Secretory transport of methylprednisolone possibly mediated by P-glycoprotein in Caco-2 cells. , 2002, Biological & pharmaceutical bulletin.

[24]  Risto Kostiainen,et al.  N-in-One Permeability Studies of Heterogeneous Sets of Compounds Across Caco-2 Cell Monolayers , 2003, Pharmaceutical Research.

[25]  J. V. Turner,et al.  Pharmacokinetic parameter prediction from drug structure using artificial neural networks. , 2004, International journal of pharmaceutics.

[26]  Malik Magdon-Ismail,et al.  No Free Lunch for Early Stopping , 1999, Neural Computation.

[27]  Fatima Martel,et al.  Uptake of Serotonin at the Apical and Basolateral Membranes of Human Intestinal Epithelial (Caco-2) Cells Occurs through the Neuronal Serotonin Transporter (SERT) , 2003, Journal of Pharmacology and Experimental Therapeutics.

[28]  M. Hashida,et al.  Prediction of Caco-2 cell permeability using a combination of MO-calculation and neural network. , 2002, International journal of pharmaceutics.

[29]  Andrew Crowe,et al.  The influence of P-glycoprotein on morphine transport in Caco-2 cells. Comparison with paclitaxel. , 2002, European journal of pharmacology.

[30]  Christer Tannergren Intestinal permeability and presystemic extraction of fexofenadine and R/S-verapamil. , 2004 .

[31]  Fumiyoshi Yamashita,et al.  The "Latent Membrane Permeability" Concept: QSPR Analysis of Inter/Intralaboratorically Variable Caco-2 Permeability , 2002, J. Chem. Inf. Comput. Sci..

[32]  U Norinder,et al.  Experimental and computational screening models for the prediction of intestinal drug absorption. , 2001, Journal of medicinal chemistry.

[33]  James E. Polli,et al.  Human Drug Absorption Kinetics and Comparison to Caco-2 Monolayer Permeabilities , 2004, Pharmaceutical Research.

[34]  L. Walker,et al.  Transport of harman alkaloids across Caco-2 cell monolayers. , 2004, Chemical & pharmaceutical bulletin.

[35]  Ann Tronde Pulmonary Drug Absorption : In vitro and in vivo investigations of drug absorption across the lung barrier and its relation to drug physicochemical properties , 2002 .

[36]  F. Lombardo,et al.  Experimental and computational approaches to estimate solubility and permeability in drug discovery and development settings. , 2001, Advanced drug delivery reviews.

[37]  Y. Martin,et al.  A bioavailability score. , 2005, Journal of medicinal chemistry.

[38]  G L Amidon,et al.  Caco-2 versus Caco-2/HT29-MTX co-cultured cell lines: permeabilities via diffusion, inside- and outside-directed carrier-mediated transport. , 2000, Journal of pharmaceutical sciences.

[39]  Kazuya Nakao,et al.  Relationships between structure and high-throughput screening permeability of diverse drugs with artificial membranes: application to prediction of Caco-2 cell permeability. , 2005, Bioorganic & medicinal chemistry.

[40]  P. Avontuur,et al.  Solubility parameter and oral absorption. , 1999, European journal of pharmaceutics and biopharmaceutics : official journal of Arbeitsgemeinschaft fur Pharmazeutische Verfahrenstechnik e.V.

[41]  Lutz Prechelt,et al.  Automatic early stopping using cross validation: quantifying the criteria , 1998, Neural Networks.

[42]  Thomas Kissel,et al.  Do cell culture conditions influence the carrier-mediated transport of peptides in Caco-2 cell monolayers? , 2003, European journal of pharmaceutical sciences : official journal of the European Federation for Pharmaceutical Sciences.

[43]  S. Ekins In silico approaches to predicting drug metabolism, toxicology and beyond. , 2003, Biochemical Society transactions.

[44]  Riccardo Leonardi,et al.  Caco-2 cell permeability modelling: a neural network coupled genetic algorithm approach , 2007, J. Comput. Aided Mol. Des..

[45]  Adam Ibrahim,et al.  Application of hydrogen bonding calculations in property based drug design. , 2002, Drug discovery today.

[46]  Ryo Shimizu,et al.  QSAR application for the prediction of compound permeability with in silico descriptors in practical use , 2009, J. Comput. Aided Mol. Des..

[47]  J. Tolan,et al.  MDCK (Madin-Darby canine kidney) cells: A tool for membrane permeability screening. , 1999, Journal of pharmaceutical sciences.

[48]  Shiew-Mei Huang,et al.  Effects of Structural Modifications on the Intestinal Permeability of Angiotensin II Receptor Antagonists and the Correlation of In Vitro, In Situ, and In Vivo Absorption , 1996, Pharmaceutical Research.

[49]  P. Artursson,et al.  Paracellular drug transport across intestinal epithelia: influence of charge and induced water flux. , 1999, European journal of pharmaceutical sciences : official journal of the European Federation for Pharmaceutical Sciences.

[50]  Z. Değim,et al.  Prediction of Permeability Coefficients of Compounds Through Caco-2 Cell Monolayer Using Artificial Neural Network Analysis , 2005, Drug development and industrial pharmacy.

[51]  Mitsuru Sugawara,et al.  Absorption of Ester Prodrugs in Caco-2 and Rat Intestine Models , 2004, Antimicrobial Agents and Chemotherapy.

[52]  M Rowland,et al.  Functional modeling of tight junctions in intestinal cell monolayers using polyethylene glycol oligomers. , 2001, American journal of physiology. Cell physiology.

[53]  S. Venkatesh,et al.  Role of the development scientist in compound lead selection and optimization. , 2000, Journal of pharmaceutical sciences.

[54]  Kristina Luthman,et al.  Theoretical Predictions of Drug Absorption in Drug Discovery and Development , 2002, Clinical pharmacokinetics.

[55]  Leann Nguyen,et al.  Is PAMPA a useful tool for discovery? , 2007, Journal of pharmaceutical sciences.

[56]  J J Baldwin,et al.  Prediction of drug absorption using multivariate statistics. , 2000, Journal of medicinal chemistry.

[57]  J. J. Voss,et al.  Permeability studies of alkylamides and caffeic acid conjugates from echinacea using a Caco‐2 cell monolayer model , 2004, Journal of clinical pharmacy and therapeutics.

[58]  Klaus-Robert Müller,et al.  Asymptotic statistical theory of overtraining and cross-validation , 1997, IEEE Trans. Neural Networks.

[59]  Ailan Guo,et al.  Membrane transport of camptothecin: facilitation by human P-glycoprotein (ABCB1) and multidrug resistance protein 2 (ABCC2) , 2004, BMC medicine.

[60]  Tingjun Hou,et al.  ADME Evaluation in Drug Discovery. 5. Correlation of Caco-2 Permeation with Simple Molecular Properties , 2004, J. Chem. Inf. Model..

[61]  Hideyuki Saito,et al.  Transport Mechanisms of Nicotine across the Human Intestinal Epithelial Cell Line Caco-2 , 2002, Journal of Pharmacology and Experimental Therapeutics.

[62]  Sean Ekins,et al.  Three-Dimensional Quantitative Structure-Permeability Relationship Analysis for a Series of Inhibitors of Rhinovirus Replication , 2001, J. Chem. Inf. Comput. Sci..

[63]  M. Yazdanian,et al.  Correlating Partitioning and Caco-2 Cell Permeability of Structurally Diverse Small Molecular Weight Compounds , 1998, Pharmaceutical Research.

[64]  T. Tsuruo,et al.  Functional expression of P-glycoprotein in apical membranes of human intestinal Caco-2 cells. Kinetics of vinblastine secretion and interaction with modulators. , 1993, The Journal of biological chemistry.

[65]  Per Artursson,et al.  Selective Paracellular Permeability in Two Models of Intestinal Absorption: Cultured Monolayers of Human Intestinal Epithelial Cells and Rat Intestinal Segments , 1993, Pharmaceutical Research.

[66]  Corwin Hansch,et al.  Comparative QSAR studies on PAMPA/modified PAMPA for high throughput profiling of drug absorption potential with respect to Caco-2 cells and human intestinal absorption , 2007, J. Comput. Aided Mol. Des..

[67]  Kevin Holme,et al.  Effect of experimental pH on the in vitro permeability in intact rabbit intestines and Caco-2 monolayer. , 2005, European journal of pharmaceutical sciences : official journal of the European Federation for Pharmaceutical Sciences.

[68]  P. Artursson,et al.  Correlation between oral drug absorption in humans and apparent drug permeability coefficients in human intestinal epithelial (Caco-2) cells. , 1991, Biochemical and biophysical research communications.

[69]  J. Sutherland,et al.  A comparison of methods for modeling quantitative structure-activity relationships. , 2004, Journal of medicinal chemistry.

[70]  Liang-Shang Gan,et al.  Mechanism of Intestinal Absorption of Ranitidine and Ondansetron: Transport Across Caco-2 Cell Monolayers , 1993, Pharmaceutical Research.

[71]  S. Chong,et al.  Validation of the 96 well Caco-2 cell culture model for high throughput permeability assessment of discovery compounds. , 2005, International journal of pharmaceutics.

[72]  W. Rubas,et al.  Comparison of the Permeability Characteristics of a Human Colonic Epithelial (Caco-2) Cell Line to Colon of Rabbit, Monkey, and Dog Intestine and Human Drug Absorption , 2004, Pharmaceutical Research.

[73]  Mats Kihlén,et al.  A General Model for Prediction of Caco‐2 Cell Permeability , 2004 .

[74]  Christoph Hiemke,et al.  How Does the Benzamide Antipsychotic Amisulpride get into the Brain?—An In Vitro Approach Comparing Amisulpride with Clozapine , 2003, Neuropsychopharmacology.

[75]  Donna A Volpe,et al.  Variability in Caco-2 and MDCK cell-based intestinal permeability assays. , 2008, Journal of pharmaceutical sciences.

[76]  Francisco Torrens,et al.  A new topological descriptors based model for predicting intestinal epithelial transport of drugs in Caco-2 cell culture. , 2004, Journal of pharmacy & pharmaceutical sciences : a publication of the Canadian Society for Pharmaceutical Sciences, Societe canadienne des sciences pharmaceutiques.

[77]  Shufeng Zhou,et al.  Determination of the investigational anti-cancer drug 5,6-dimethylxanthenone-4-acetic acid and its acyl glucuronide in Caco-2 monolayers by liquid chromatography with fluorescence detection: application to transport studies. , 2004, Journal of chromatography. B, Analytical technologies in the biomedical and life sciences.

[78]  Marc Parham,et al.  Prediction of aqueous solubility based on large datasets using several QSPR models utilizing topological structure representation. , 2004, Chemistry & biodiversity.

[79]  Shiyin Yee,et al.  In Vitro Permeability Across Caco-2 Cells (Colonic) Can Predict In Vivo (Small Intestinal) Absorption in Man—Fact or Myth , 1997, Pharmaceutical Research.

[80]  U. Christians,et al.  Active transport of the angiotensin‐II antagonist losartan and its main metabolite EXP 3174 across MDCK‐MDR1 and Caco‐2 cell monolayers , 2000, British journal of pharmacology.

[81]  I. Tetko,et al.  Application of ALOGPS to predict 1-octanol/water distribution coefficients, logP, and logD, of AstraZeneca in-house database. , 2004, Journal of pharmaceutical sciences.

[82]  Guang-Ji Wang,et al.  Transport and uptake characteristics of a new derivative of berberine (CPU-86017) by human intestinal epithelial cell line: Caco-2. , 2003, Acta pharmacologica Sinica.

[83]  G Folkers,et al.  Estimation of permeability by passive diffusion through Caco-2 cell monolayers using the drugs' lipophilicity and molecular weight. , 1998, European journal of pharmaceutical sciences : official journal of the European Federation for Pharmaceutical Sciences.

[84]  A. Mitra,et al.  Interactions of the Dipeptide Ester Prodrugs of Acyclovir with the Intestinal Oligopeptide Transporter: Competitive Inhibition of Glycylsarcosine Transport in Human Intestinal Cell Line-Caco-2 , 2003, Journal of Pharmacology and Experimental Therapeutics.

[85]  K. Luthman,et al.  Correlation of drug absorption with molecular surface properties. , 1996, Journal of pharmaceutical sciences.

[86]  Bart Willems,et al.  Usefulness of a novel Caco-2 cell perfusion system. I. In vitro prediction of the absorption potential of passively diffused compounds. , 2004, Journal of pharmaceutical sciences.

[87]  Henrike Potthast,et al.  Biopharmaceutical characterization of sotalol-containing oral immediate release drug products. , 2004, European journal of pharmaceutics and biopharmaceutics : official journal of Arbeitsgemeinschaft fur Pharmazeutische Verfahrenstechnik e.V.

[88]  David A Winkler,et al.  Neural networks as robust tools in drug lead discovery and development , 2004, Molecular biotechnology.

[89]  Kikuo Iwamoto,et al.  Transepithelial permeation of tolbutamide across the human intestinal cell line, Caco-2. , 2004, Drug metabolism and pharmacokinetics.

[90]  Istvan Toth,et al.  Determination of transport in the Caco-2 cell assay of compounds varying in lipophilicity using LC-MS: enhanced transport of Leu-enkephalin analogues. , 2002, European journal of pharmaceutical sciences : official journal of the European Federation for Pharmaceutical Sciences.

[91]  D. Butina,et al.  Performance of Kier-Hall E-state descriptors in quantitative structure activity relationship (QSAR) studies of multifunctional molecules. , 2004, Molecules.

[92]  Maria Guangli,et al.  Predicting Caco-2 permeability using support vector machine and chemistry development kit. , 2006, Journal of pharmacy & pharmaceutical sciences : a publication of the Canadian Society for Pharmaceutical Sciences, Societe canadienne des sciences pharmaceutiques.

[93]  G. Caldwell,et al.  In vitro permeability of eight beta-blockers through Caco-2 monolayers utilizing liquid chromatography/electrospray ionization mass spectrometry. , 1998, Journal of mass spectrometry : JMS.

[94]  H Lennernäs,et al.  Jejunal permeability in humans in vivo and rats in situ: investigation of molecular size selectivity and solvent drag. , 1999, Acta physiologica Scandinavica.

[95]  Philippe Arnaud,et al.  Short term Caco-2/TC7 cell culture: comparison between conventional 21-d and a commercially available 3-d system. , 2004, Biological & pharmaceutical bulletin.

[96]  Denis M. Bayada,et al.  Polar Molecular Surface as a Dominating Determinant for Oral Absorption and Brain Penetration of Drugs , 1999, Pharmaceutical Research.

[97]  Roberto Todeschini,et al.  Handbook of Molecular Descriptors , 2002 .

[98]  G Beck,et al.  Evaluation of human intestinal absorption data and subsequent derivation of a quantitative structure-activity relationship (QSAR) with the Abraham descriptors. , 2001, Journal of pharmaceutical sciences.

[99]  Francisco Torrens,et al.  Estimation of ADME properties in drug discovery: predicting Caco-2 cell permeability using atom-based stochastic and non-stochastic linear indices. , 2007, Journal of pharmaceutical sciences.

[100]  Ning Li,et al.  Hormonal regulation of dipeptide transporter (PepT1) in Caco-2 cells with normal and anoxia/reoxygenation management. , 2003, World journal of gastroenterology.

[101]  Andrew Crowe,et al.  In Vitro and In Situ Absorption of SDZ-RAD Using a Human Intestinal Cell Line (Caco-2) and a Single Pass Perfusion Model in Rats: Comparison with Rapamycin , 1998, Pharmaceutical Research.

[102]  Gordon L. Amidon,et al.  Comparison of Human Duodenum and Caco-2 Gene Expression Profiles for 12,000 Gene Sequences Tags and Correlation with Permeability of 26 Drugs , 2002, Pharmaceutical Research.

[103]  J. Finley,et al.  The Influence of Culture Time and Passage Number on the Morphological and Physiological Development of Caco-2 Cells , 1997, Proceedings of the Society for Experimental Biology and Medicine. Society for Experimental Biology and Medicine.

[104]  Ismael Zamora,et al.  pH-Dependent Bidirectional Transport of Weakly Basic Drugs Across Caco-2 Monolayers: Implications for Drug–Drug Interactions , 2003, Pharmaceutical Research.

[105]  Fumiyoshi Yamashita,et al.  Quantitative structure/property relationship analysis of Caco-2 permeability using a genetic algorithm-based partial least squares method. , 2002, Journal of pharmaceutical sciences.

[106]  Kazuya Nakao,et al.  QSAR study on permeability of hydrophobic compounds with artificial membranes. , 2007, Bioorganic & medicinal chemistry.

[107]  Kristina Luthman,et al.  Polar Molecular Surface Properties Predict the Intestinal Absorption of Drugs in Humans , 1997, Pharmaceutical Research.

[108]  Marjo Yliperttula,et al.  Computational prediction of oral drug absorption based on absorption rate constants in humans. , 2006, Journal of medicinal chemistry.

[109]  Igor V. Tetko,et al.  Neural Network Studies, 2. Variable Selection , 1996, J. Chem. Inf. Comput. Sci..

[110]  Tingjun Hou,et al.  ADME evaluation in drug discovery , 2002, Journal of molecular modeling.

[111]  Thomas Walle,et al.  Cellular Uptake and Efflux of the Tea Flavonoid (-)Epicatechin-3-gallate in the Human Intestinal Cell Line Caco-2 , 2003, Journal of Pharmacology and Experimental Therapeutics.

[112]  Gregg D. Wilensky,et al.  Neural Network Studies , 1993 .

[113]  P. Gramatica,et al.  Modelling and prediction of soil sorption coefficients of non-ionic organic pesticides by molecular descriptors. , 2000, Chemosphere.

[114]  Araz A. Raoof,et al.  In Vivo Assessment of Intestinal, Hepatic, and Pulmonary First Pass Metabolism of Propofol in the Rat , 1996, Pharmaceutical Research.

[115]  U Norinder,et al.  Theoretical calculation and prediction of drug transport processes using simple parameters and partial least squares projections to latent structures (PLS) statistics. The use of electrotopological state indices. , 2001, Journal of pharmaceutical sciences.